Double-blind, Randomized, Parallel, Placebo-controlled Clinical Study to Evaluate the Viral Load of SARS-CoV-2 (COVID-19) in the Oral Cavity of SARS-CoV-2 Positive Subjects After the Use of a Mouthwash Containing Cetylpyridinium Chloride 0,07%.

NACompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

February 17, 2021

Primary Completion Date

May 25, 2021

Study Completion Date

June 3, 2021

Conditions
SARS-CoV-2 Infection
Interventions
OTHER

0.07% cetylpyridinium chloride (CPC) in mouthwash

A mouthwash and gargles with 15 ml of 0.07% cetylpyridinium chloride (CPC) in mouthwash for 1 minute.

OTHER

Distilled water with the same colorant as the experimental product

A mouthwash and gargles with 15 ml of distilled water for 1 minute

Trial Locations (19)

08913

CAP Gorg, Badalona

08914

CAP Gran Sol, Badalona

08918

CAP St Roc, Badalona

08921

CAP Barri Llatí, Santa Coloma de Gramenet

08923

CAP Fondo, Santa Coloma de Gramenet

CAP Santa Rosa, Santa Coloma de Gramenet

08924

CAP Singuerlin, Santa Coloma de Gramenet

08911

CAP Dr Robert, Badalona

08521

CAP Les Franqueses del Vallès, Bellavista

08420

CAP Canovelles/Granollers Oest, Canovelles

08401

CAP Granollers Centre, Granollers

08302

ABS Gatassa, Mataró

08470

EAP Mollet Est, Mollet del Vallès

CAP Sant Celoni, Sant Celoni

08170

CAP Montornés/Montmeló, Montornés Del Vallès

08184

CAP Palau, Palau-solità i Plegamans

08150

EAP Parets del Vallès, Parets del Vallès

08130

CAP Santa Perpètua, Santa Perpètua de Mogoda

08340

EAP Vilassar de Mar, Vilassar de Mar

All Listed Sponsors
collaborator

IrsiCaixa

OTHER

collaborator

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

OTHER

lead

Dentaid SL

INDUSTRY

NCT04757818 - Double-blind, Randomized, Parallel, Placebo-controlled Clinical Study to Evaluate the Viral Load of SARS-CoV-2 (COVID-19) in the Oral Cavity of SARS-CoV-2 Positive Subjects After the Use of a Mouthwash Containing Cetylpyridinium Chloride 0,07%. | Biotech Hunter | Biotech Hunter